{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-018029","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2024-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.165978+00:00","generated_at":"2026-06-01T09:36:27.129560+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cassava Sciences awards $850k in discretionary bonuses to execs; CFO gets change-in-control severance","bullets":["CEO Remi Barbier receives $500k discretionary cash bonus.","CFO Eric Schoen receives $250k bonus; employment amended to include 12-month severance after change in control.","General Counsel R. Christopher Cook and CMO James Kupiec each receive $50k bonus.","Change in control defined as acquisition of 51% or more of outstanding shares."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-018029","json":"https://secwatch.observer/filing/0001437749-24-018029.json","markdown":"https://secwatch.observer/filing/0001437749-24-018029.md","text":"https://secwatch.observer/filing/0001437749-24-018029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018029/0001437749-24-018029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000143774924018029/sava20240521_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:36:27.129560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}